124.65000 EUR
0.45
0.36%
Last update Dec 15, 7:30 PM CET
Main market
Day range
124.050003
125.70000
Previous close
124.20000
Open
125.55000
Access this stock data via API
Subscribe
Axsome Therapeutics, Inc.
124.65
0.45
0.36%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 145.6M 127.8M 103.5M 101.2M
Cost of revenue 10.1M 11.5M 8.3M 9.0M
Gross profit 135.5M 116.3M 95.1M 92.2M
Operating expense
Research & development 34.2M 42.2M 38.1M 46.9M
Selling general and admin 128.0M 111.0M 102.9M 96.5M
Other operating expenses
Operating income -28.0M -38.2M -47.2M -52.5M
Non operating interest income
Income
Expense 954.0K 1.6M 2.1M 1.9M
Other income expense -11.2M -1.9M -1.3M -9.4M
Pretax income -40.2M -41.7M -50.6M -63.7M
Tax provision 0 -817.7K 0 72.4K
Net income -40.2M -40.9M -50.6M -63.8M
Basic EPS -1.0 -1.2 -1.5
Diluted EPS -1.0 -1.2 -1.5
Basic average shares 42.1M 41.6M 41.3M
Diluted average shares 42.1M 41.6M 41.3M
EBITDA -26.0M -36.3M -45.4M -50.7M
Net income from continuing op. -40.2M -40.9M -50.6M -63.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 40 minutes

14:19
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).